Status:
COMPLETED
Skin Biopsy Specimens as Biomarkers of Systemic Sclerosis and Response to Mycophenolate Mofetil
Lead Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborating Sponsors:
Dartmouth-Hitchcock Medical Center
Conditions:
Systemic Sclerosis
Eligibility:
All Genders
19-90 years
Brief Summary
The purpose of this study is to assess whether skin biopsy specimens from patients with diffuse cutaneous systemic sclerosis (dcSSc) can be used as biomarkers (measures of activity and type) of diseas...
Detailed Description
Systemic sclerosis (SSc) is an autoimmune connective tissue disease primarily affecting young to middle-aged women. The pathogenesis of SSc is complex involving interplay of three seemingly diverse pr...
Eligibility Criteria
Inclusion
- 18 years of age
- systemic sclerosis
Exclusion
- pregnant
- bleeding disorder
- history of delayed wound healing
Key Trial Info
Start Date :
November 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00853788
Start Date
November 1 2008
End Date
June 1 2011
Last Update
February 17 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern Memorial Faculty Foundation
Chicago, Illinois, United States, 60611